Circulation

SEPTEMBER 10, 2024

Circulation, Ahead of Print. Early identification of kidney dysfunction in patients with advanced heart failure is crucial for timely interventions. Hemodynamic derangements and maladaptive neurohormonal upregulations contribute to fluctuations in kidney indices and electrolytes that may recover with guideline-directed medical therapy.

Heart Failure 80

Heart Failure Kidney Disease Heart Transplant Transplant 80

Circulation: Genomic and Precision Medicine

SEPTEMBER 28, 2023

Circulation: Genomic and Precision Medicine, Volume 16, Issue 5 , Page 452-461, October 1, 2023. Background:Many cardiovascular disorders propel the development of advanced heart failure that necessitates cardiac transplantation.

Heart Transplant 40

Heart Transplant Transplant Cardiomyopathy Pediatrics 40

Circulation

FEBRUARY 26, 2024

Circulation, Ahead of Print. Individual programs oftentimes develop upper age limits for various interventional strategies for their patients, including heart transplantation and durable left ventricular assist devices.

Cardiogenic Shock 74

Cardiogenic Shock Best Practices Heart Transplant Transplant 74

Circulation: Heart Failure

AUGUST 1, 2024

Circulation: Heart Failure, Ahead of Print.

Heart Transplant 40

Heart Transplant Education Transplant Heart Failure 40

Circulation: Heart Failure

DECEMBER 11, 2023

Circulation: Heart Failure, Ahead of Print.

Heart Transplant 40

Heart Transplant Transplant Heart Failure Circulation 40

DAIC

APRIL 30, 2024

Heart attacks typically kill millions of cardiac muscle cells, leaving the heart in a weakened state. Since mammals cannot regenerate cardiac muscle cells on their own, heart transplants are currently the only clinically viable option for patients suffering (or likely to suffer) heart failure.

Transplant 105

Transplant Heart Transplant Myocardial Infarction Heart attacks 105

Circulation: Heart Failure

NOVEMBER 6, 2023

Circulation: Heart Failure, Ahead of Print.

Heart Transplant 40

Heart Transplant Transplant Heart Failure Circulation 40

Circulation: Heart Failure

FEBRUARY 5, 2024

Circulation: Heart Failure, Ahead of Print. BACKGROUND:Cardiac allograft vasculopathy (CAV) is the leading cause of late graft dysfunction in heart transplantation.

Heart Transplant 40

Heart Transplant Ultrasound Transplant Heart Failure 40

DAIC

MAY 15, 2024

It can be used while waiting for a heart transplant, to help the heart recover, or as a permanent solution when a transplant isn't an option. HeartMate 3 LVAS takes over the pumping function of the left ventricle, the main pumping chamber of the heart.

Transplant 105

Transplant Heart Failure Heart Transplant Pediatrics 105

DAIC

APRIL 15, 2024

.: 13,883 Date Initiated by Firm: February 19, 2024 Device Use The HeartMate II and HeartMate 3 Left Ventricular Assist Systems (LVAS) are used to help the heart pump blood when it's not able to do so effectively on its own. Both devices work by taking over the pumping function of the left ventricle, the main pumping chamber of the heart.

Transplant 105

Transplant Heart Transplant Pediatrics Heart Failure 105

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4146828-A4146828, November 12, 2024. Heart transplantation remains a vital treatment for end-stage heart failure, yet the scarcity of suitable donor hearts makes the treatment unavailable to many patients in critical need.

Transplant 40

Transplant Heart Transplant Heart Dysfunction Heart Failure 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4113494-A4113494, November 12, 2024. End-stage ischemic heart disease necessitates heart transplantation, and emerging cell therapy presents a promising solution to address donor scarcity.

Ischemia 40

Ischemia Transplant Heart Transplant Biomarkers 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4134590-A4134590, November 12, 2024. The association between a lower rate of MAE and EMB persisted in the multivariate model when those with heart transplant who had EMB were compared to those without heart transplant who did not have EMB p=0.001.

Cardiomyopathy 40

Cardiomyopathy Pediatrics Heart Transplant Heart Failure 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4146823-A4146823, November 12, 2024. Heart transplant rates were low but increased slightly in 2020 for patients without CHD, with DV and SV CHD patients showing fluctuating rates peaking in 2018 and 2019, then declining in 2020.

Cardiogenic Shock 40

Cardiogenic Shock Congenital Heart Disease Heart Failure Congenital 40

Circulation: Heart Failure

MARCH 8, 2024

Circulation: Heart Failure, Ahead of Print. Centers performing at least 1 heart transplant or left ventricular assist device were classified as ATCs. Patient characteristics, outcomes, and procedural volume were compared among 3 cohorts: admissions to non-ATCs, admissions to ATCs, and transfers to ATCs.

Heart Failure 40

Heart Failure Cardiogenic Shock Outcomes Cardiac Arrest 40

Circulation: Heart Failure

FEBRUARY 1, 2024

Circulation: Heart Failure, Ahead of Print. BACKGROUND:Clinical evaluation of central venous pressure is difficult, depends on experience, and is often inaccurate in patients with chronic advanced heart failure. 0.84]) and confirmed in the validation cohort (receiver operating characteristic, 0.82 [95% CI, 0.73–0.92]).

Heart Failure 40

Heart Failure Ultrasound Heart Transplant Pulmonary 40

Circulation

JANUARY 18, 2024

Circulation, Ahead of Print. BACKGROUND:Cardiolipin is a mitochondrial-specific phospholipid that maintains integrity of the electron transport chain (ETC) and plays a central role in myocardial ischemia/reperfusion injury. Tafazzin is an enzyme that is required for cardiolipin maturation.

Myocardial Infarction 45

Myocardial Infarction Heart Transplant Ischemia Transplant 45

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4144326-A4144326, November 12, 2024. It has changed the fate of young patients with large tumors who would have otherwise needed heart transplants, offering high suture strength and reducing postoperative complications. During a median follow-up period of 17.4

Pediatrics 40

Pediatrics Outcomes Heart Transplant Aneurysm 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4146920-A4146920, November 12, 2024. Introduction:Perioperative anemia can cause a host of complications, such as renal injury, stroke, and mortality. However, the use of transfusions preoperatively also can cause various complications, such as an overload of fluids and the risk of infection.

Transplant 40

Transplant Heart Transplant Risk Factors Outcomes 40

Circulation: Heart Failure

FEBRUARY 1, 2024

Circulation: Heart Failure, Ahead of Print. BACKGROUND:In 2018, an algorithm-based allocation system for heart transplantation (HT) was implemented in France.

Heart Failure 40

Heart Failure Congenital Heart Disease Congenital Outcomes 40

Circulation: Cardiovascular Imaging

DECEMBER 18, 2023

Circulation: Cardiovascular Imaging, Volume 16, Issue 12 , Page e015671, December 1, 2023. LV global longitudinal strain did not add diagnostic value but was prognostic for composite end points of death, heart transplantation, or ventricular arrhythmia (log-rankP=0.04).CONCLUSIONS:In

Cardiomyopathy 40

Cardiomyopathy Heart Transplant Cardiovascular Imaging Transplant 40

MIBHS

OCTOBER 31, 2024

Left Ventricular Assist Device (LVAD) , a mechanical pump that helps the heart pump blood more effectively. Implantable Cardioverter-Defibrillator (ICD) to help manage dangerous heart rhythms. Heart Transplant may be considered in severe cases where other treatments have failed. Avoid smoking and limit alcohol intake.

Blood Pressure 52

Blood Pressure Blood Clot Heart Valves Heart Rhythm 52

Cardiology Update

APRIL 9, 2024

The Impella CP is a catheter-based, axial flow pump that pumps blood directly from the left ventricle into the circulation. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes.

Myocardial Infarction 52

Myocardial Infarction Angina Aortic valve Coronary Artery Disease 52

Dr. Smith's ECG Blog

JUNE 2, 2023

J Electrocardiol, 42 (2009), pp. e5 Article Download PDF Google Scholar 3 RNW Hauer, MGPJ Cox, JA Groeneweg Impact of new electrocardiographic criteria in arrhythmogenic cardiomyopathy Front Physiol, 3 (2012), p.

Tachycardia 83

Tachycardia Cardiomyopathy Electrocardiogram Article 83

Circulation: Heart Failure

FEBRUARY 20, 2024

Circulation: Heart Failure, Ahead of Print. Background:Black heart transplant patients are at higher risk of acute rejection (AR) and death than White patients. In a multivariable model, Black patient race (hazard ratio, 2.61 [95% CI, 1.35–5.04];P=0.004) 5.04];P=0.004) and %dd-cfDNA (hazard ratio, 1.15 [95% CI, 1.03–1.28];P=0.010)

Heart Transplant 40

Heart Transplant Transplant Heart Failure Outcomes 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4139383-A4139383, November 12, 2024. Background:Immunosuppressive (IS) therapy is currently used as first-line treatment for heart transplant (HTx) rejection. However, they are not without complications, and less toxic therapies are needed.

Heart Transplant 40

Heart Transplant Transplant Cardiovascular Disease Outcomes 40

Dr. Paddy Barrett

MAY 31, 2024

The prevalence of smoking back in the 1950s would have been much higher, but even recent studies on ‘healthy’ heart transplant donors who died from events such as road traffic accidents still show high rates of very early-stage plaque buildup 4. Circulation. Circulation. Am J Cardiol. 2006 Jan 3;113(1):30-7.

Heart Disease 78

Heart Disease Plaque Heart Attack Heart attacks 78

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4138589-A4138589, November 12, 2024. All patients were prospectively followed for development of new outcome/cardiac events which included hospitalization for acute HF, CVS-related death, heart transplantation, and also diabetic complications.

Coronary Artery Disease 40

Coronary Artery Disease Diabetes Heart Transplant Tricuspid 40

Circulation: Genomic and Precision Medicine

SEPTEMBER 6, 2023

Circulation: Genomic and Precision Medicine, Volume 16, Issue 5 , Page 421-430, October 1, 2023. Background:Variants in theDMDgene, that encodes the cytoskeletal protein, dystrophin, cause a severe form of dilated cardiomyopathy (DCM) associated with high rates of heart failure, heart transplantation, and ventricular arrhythmias.

Cardiomyopathy 40

Cardiomyopathy Heart Transplant Transplant Heart Failure 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Part 1: Concepts, Indicator Variables, and Controversies The Annals of Thoracic Surgery January 2022 Arman Kilic Supplementing Existing Societal Risk Models for Surgical Aortic Valve Replacement With Machine Learning for Improved Prediction Journal of the American Heart Association November 2021 Jared Belle Strategies for Mechanical Right Ventricular (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52